Moderna Says Committed to Making Omicron-adaptive Vaccine Candidate Available in Aug. - The Korea Bizwire

SEOUL, July 19 (Korea Bizwire) – Moderna Inc., a U.S. biotech company specializing in messenger RNA (mRNA) coronavirus vaccines, is …

This photo provided by U.S. biotech firm Moderna Inc.’s South Korean unit shows Francesca Ceddia, senior vice president of respiratory vaccines, speaking to reporters at a press conference at a Seoul… [+2822 chars]

full article...